ICB, the trustee of 62 mutual funds, has proposed that at least 25% of the profit earned by mutual funds in the current fiscal year be kept as provisioning, while the remaining 75% be distributed as d ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.

LLR Partners has made a growth investment in TruTechnologies, a Research Triangle Park, North Carolina-based provider of real ...

Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Puma Biotech (PBYI) could be a great choice. It is one of the several stocks that ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...

A former employee of AmplifyBio is suing the shuttered biotechnology firm, alleging the company laid off its workers without ...

Mark Hartley considers how a Stocks and Shares ISA could help investors capitalise on the UK market bounceback and aim for ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

Entrepreneur and politician Vivek Ramaswamy made much of his fortune founding biotechnology companies and trading their stocks, but now the former GOP presidential candidate and current contender for ...